title: [Effects of selective laser trabeculoplasty treatment in steroid-induced glaucoma].
abstract: OBJECTIVE
  To evaluate the effectiveness of selective laser trabeculoplasty (SLT) on steroid-induced glaucoma.
  
  
  METHODS
  The study included 46 eyes of 41 subjects who were followed up for at least 12 months after SLT. The included 10 eyes with steroid-induced glaucoma, 16 eyes with primary open angle glaucoma (POAG), 10 eyes with pseudoexfoliation glaucoma (PEX.G) and 10 eyes with mixed glaucoma (Mixed. G). The range of the SLT laser was 360 degrees. Intraocular pressure (IOP) before and after SLT, and cumulative survival rate after SLT were determined.
  
  
  RESULTS
  Significant decreases in IOP were observed after SLT in the steroid-induced glaucoma group, the POAG group and the PEX.G group. At 12 months after SLT, preoperation IOP decreased by 35.9% (29.9 +/- 7.5 mmHg to 17.9 +/- 2.2 mmHg) in the steroid-induced glaucoma group, 13.2% (20.0 +/- 3.0 mmHg to 17.3 +/- 3.1 mmHg) in the POAG group, 10.7% (21.1 +/- 4.0 mmHg to 18.1 +/- 4.1 mmHg) in the PEX.G group and 6.9% (21.3 +/- 1.9 mmHg to 19.9 +/- 3.4 mmHg) in the Mixed.G group. Cumulative survival rates were 80%, 56.3%, 50.0%, 40.0% in the steroid-induced glaucoma, POAG, PEX.G, and Mixed. G groups, respectively, at 12 months after SLT (Logrank test, p = 0.467).
  
  
  CONCLUSIONS
  These data suggest that SLT increased IOP reduction rates for steroid-induced glaucoma more than for any other group.
authors.affiliation: Department of Ophthalmology, St Marianna University School of Medicine. Japan. tokunao@nifty.com
authors.forename: Naoto
authors.initials: N
authors.lastname: Tokuda
authors.forename: Jun
authors.initials: J
authors.lastname: Inoue
authors.forename: Izumi
authors.initials: I
authors.lastname: Yamazaki
authors.forename: Akiko
authors.initials: A
authors.lastname: Matsuzawa
authors.forename: Yasunari
authors.initials: Y
authors.lastname: Munemasa
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Kitaoka
authors.forename: Hitoshi
authors.initials: H
authors.lastname: Takagi
authors.forename: Satoki
authors.initials: S
authors.lastname: Ueno
mesh_terms: D000293:Adolescent; D000328:Adult; D001623:Betamethasone / Q000009:adverse effects*; D002648:Child; D005260:Female; D005901:Glaucoma / Q000139:chemically induced* / Q000503:physiopathology / Q000601:surgery*; D006801:Humans; D007429:Intraocular Pressure; D053685:Laser Therapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011239:Prednisolone / Q000009:adverse effects*; D014130:Trabeculectomy / Q000379:methods*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D001623:Betamethasone; D011239:Prednisolone